Karen Akinsanya
Director/Board Member at NAUTILUS BIOTECHNOLOGY, INC.
Net worth: - $ as of 2024-04-29
Profile
Karen Akinsanya is the founder of Envision Science Group LLC, which was founded in 2007.
She holds the title of President at Envision Science Group LLC.
Dr. Akinsanya's current jobs include being an Independent Director at Nautilus Biotechnology, Inc. since 2022, a Trustee at The Rockefeller University, and the President-Research & Development Therapeutics at Schrödinger, Inc. since 2018.
Dr. Akinsanya's former job was as a Vice President at Merck & Co., Inc. from 2013 to 2017.
She received her undergraduate degree from Queen Mary University of London and her doctorate from Royal Postgraduate Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCHRODINGER, INC.
-.--% | 2024-03-31 | 0 ( -.--% ) | - $ | 2024-04-29 |
Karen Akinsanya active positions
| Companies | Position | Start |
|---|---|---|
| SCHRÖDINGER, INC. | Corporate Officer/Principal | 2018-03-31 |
| NAUTILUS BIOTECHNOLOGY, INC. | Director/Board Member | 2022-03-29 |
| Envision Science Group LLC | Founder | 2006-12-31 |
| The Rockefeller University | Director/Board Member | - |
Former positions of Karen Akinsanya
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 2017-06-30 |
Training of Karen Akinsanya
| Queen Mary University of London | Undergraduate Degree |
| Royal Postgraduate Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Envision Science Group LLC |
- Stock Market
- Insiders
- Karen Akinsanya